Abstract: The present invention relates to a compound of the Formula (I)): or pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same, a method for treating or preventing viral infections, inflammation, dry eye, central nervous disorders, cardiovascular diseases, cancer, obesity, diabetes, muscular dystrophy, and hair loss.
Type:
Grant
Filed:
December 15, 2017
Date of Patent:
May 12, 2020
Assignee:
S&T GLOBAL INC.
Inventors:
Zhuang Su, Zhengyu Long, Zhennian Huang, Suizhou Yang
Abstract: The present invention relates to a compound of the Formula (I)): or pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same, a method for treating or preventing viral infections, inflammation, dry eye, central nervous disorders, cardiovascular diseases, cancer, obesity, diabetes, muscular dystrophy, and hair loss.
Type:
Grant
Filed:
March 15, 2013
Date of Patent:
February 13, 2018
Assignee:
S&T Global Inc.
Inventors:
Zhuang Su, Zhengyu Long, Zhennian Huang, Suizhou Yang
Abstract: The present invention relates to a compound of the formula (I), (II), (III), (IV), (V), or (VI) or pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same, a method for treating or preventing a viral infection using the same.
Type:
Grant
Filed:
August 12, 2011
Date of Patent:
February 21, 2017
Assignee:
S&T GLOBAL, INC.
Inventors:
Zhuang Su, Zhengyu Long, Zhennian Huang, Suizhou Yang
Abstract: The present invention relates to a compound of the Formula (I)): or pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same, a method for treating or preventing viral infections, inflammation, dry eye, central nervous disorders, cardiovascular diseases, cancer, obesity, diabetes, muscular dystrophy, and hair loss.
Abstract: The present invention relates to a compound of the formula (I): or pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same, a method for treating or preventing a viral infection using the same.
Type:
Grant
Filed:
July 18, 2011
Date of Patent:
December 22, 2015
Assignee:
S&T Global Inc.
Inventors:
Zhuang Su, Zhennian Huang, Zhengyu Long, Suizhou Yang
Abstract: The present invention relates to a compound of the Formula (I)): or pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same, a method for treating or preventing viral infections, inflammation, dry eye, central nervous disorders, cardiovascular diseases, cancer, obesity, diabetes, muscular dystrophy, and hair loss.